Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Name: Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
License: Public Domain

Dartmouth-Hitchcock Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic renal cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 208250
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.